Michael Donegan
2014
In 2014, Michael Donegan earned a total compensation of $341.6K as Vice President - Finance at TherapeuticsMD.
Compensation breakdown
| Non-Equity Incentive Plan | $20,000 |
|---|---|
| Option Awards | $161,210 |
| Salary | $150,000 |
| Other | $10,364 |
| Total | $341,574 |
Donegan received $161.2K in option awards, accounting for 47% of the total pay in 2014.
Donegan also received $20K in non-equity incentive plan, $150K in salary and $10.4K in other compensation.
Rankings
In 2014, Michael Donegan's compensation ranked 11,426th out of 13,032 executives tracked by ExecPay. In other words, Donegan earned more than 12.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,426 out of 13,032 | 12th |
Division Manufacturing | 4,375 out of 4,966 | 12th |
Major group Chemicals And Allied Products | 1,515 out of 1,686 | 10th |
Industry group Drugs | 1,227 out of 1,365 | 10th |
Industry Pharmaceutical Preparations | 942 out of 1,043 | 10th |
Source: SEC filing on April 25, 2017.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2014.